The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example.
about
Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordomaBreast Cancer Reporting in Lagos, Nigeria: Implications for Training and Education in Africa.Development of automated quantification methodologies of immunohistochemical markers to determine patterns of immune response in breast cancer: a retrospective cohort study.Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.Evaluation of cytokeratin-19 in breast cancer tissue samples: a comparison of automatic and manual evaluations of scanned tissue microarray cylinders.Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.Overview on Techniques to Construct Tissue Arrays with Special Emphasis on Tissue Microarrays.The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy.Safety biomarkers in preclinical development: translational potential.The value of archival tissue blocks in understanding breast cancer biology.Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosisBasal markers and prognosis in luminal breast cancer.Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.
P2860
Q33274950-1A1B4575-3706-41BA-8DF1-476DEDA8F8B3Q33859652-90931E8D-54BB-41BA-B0F6-698D20E15FA8Q34024612-2E5D28DC-91AC-4C76-ADCD-348F40AE923AQ35709269-ADDAF7DC-5994-4130-BBF6-3833230FD9F3Q35989561-180A7E2E-7D42-4A8D-B4F9-A9A31D9735F9Q36873786-8634DCFB-3130-49F0-BC5A-B0E30EA7A8F3Q37214193-69D8FE75-1EF4-477B-B6E6-6F8D5DC40BB4Q37470103-1A95EB9D-C104-46F3-9C3B-4185BE65011DQ37565327-8277CC47-8BC1-4283-9436-61AECC4EC3D7Q38148980-3B09778D-A2AF-4EB9-A43C-91AB56A1E88FQ38394410-3D2C62CF-92AF-43D2-8980-7D8F282E7F2DQ42290635-A0D00041-CDDD-4ADE-942C-D20852127905Q42506475-6DC5A392-247C-4693-9789-2F8C5EBBE742Q49868941-09040E9A-BD8C-4817-96B0-4DB8782DE7CAQ50695266-3FD70948-B494-408E-990F-3D846B2EB5A1
P2860
The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The manufacture and assessment ...... h breast cancer as an example.
@en
The manufacture and assessment ...... h breast cancer as an example.
@en-gb
type
label
The manufacture and assessment ...... h breast cancer as an example.
@en
The manufacture and assessment ...... h breast cancer as an example.
@en-gb
prefLabel
The manufacture and assessment ...... h breast cancer as an example.
@en
The manufacture and assessment ...... h breast cancer as an example.
@en-gb
P2093
P50
P1476
The manufacture and assessment ...... h breast cancer as an example.
@en
P2093
Alastair M Thompson
Cheryl Gillett
John P Brown
Translational Subgroup of the NCRI Breast Clinical Studies Group
P304
P356
10.1136/JCLINPATH-2012-201091
P407
P577
2012-10-19T00:00:00Z